The benefit of LTR’s business model is a significantly reduced time to approval and lower cost, even when compared with traditional drug repurposing strategies as shown below:
The Global ED Market is expected to generate revenue of USD $7.10 BN by the end of 2026
9/204 Alice Street, Brisbane QLD 4000
Phone: 1800 519 711